Crude | Adjusted | |||||||
B | OR | 95% CI | P value | B | OR | 95% CI | P value | |
Alpha-HCH | 0.27 | 1.31 | 1.44 to 1.19 | <0.001 | 0.29 | 1.34 | 1.20 to 1.49 | <0.001 |
Q1 (≤1) | Ref | Ref | Ref | – | Ref | Ref | Ref | – |
Q2 (1–2) | 0.77 | 2.17 | 0.81 to 5.79 | 0.11 | 0.75 | 2.12 | 0.76 to 5.88 | 0.14 |
Q3 (2–3) | 0.61 | 1.84 | 0.75 to 4.49 | 0.17 | 0.48 | 1.63 | 0.64 to 4.11 | 0.31 |
Q4 (>3) | 1.49 | 4.42 | 1.75 to 11.15 | 0.002* | 1.57 | 4.82 | 1.83 to 12.68 | 0.001* |
Beta-HCH | 0.43 | 1.53 | 1.31 to 1.79 | <0.001 | 0.43 | 1.54 | 1.30 to 1.82 | <0.001 |
Q1 (≤1.74) | Ref | Ref | Ref | – | Ref | Ref | Ref | – |
Q2 (1.74–4.34) | 0.72 | 2.06 | 0.84 to 5.07 | 0.11 | 0.74 | 2.11 | 0.83 to 5.37 | 0.11 |
Q3 (4.34–7.11) | 1.42 | 4.13 | 1.62 to 10.54 | 0.003* | 1.41 | 4.11 | 1.55 to 10.87 | 0.004* |
Q4 (>7.11) | 1.16 | 3.19 | 1.21 to 8.37 | 0.01* | 1.17 | 3.23 | 1.17 to 8.92 | 0.02* |
Gamma-HCH | 0.44 | 1.56 | 1.31 to 1.84 | <0.001 | 0.46 | 1.58 | 1.31 to 1.91 | <0.001 |
Q1 (≤1.38) | Ref | Ref | Ref | – | Ref | Ref | Ref | – |
Q2 (1.38–2.92) | 0.57 | 1.77 | 0.63 to 4.94 | 0.27 | 0.36 | 1.44 | 0.48 to 4.22 | 0.51 |
Q3 (2.92–6.71) | 1.07 | 2.91 | 1.21 to 7.05 | 0.01* | 1.14 | 3.14 | 1.23 to 8.03 | 0.01* |
Q4 (>6.71) | 1.32 | 3.73 | 1.52 to 9.17 | 0.004* | 1.15 | 3.15 | 1.23 to 8.07 | 0.01* |
2,4-DDE | 0.18 | 1.21 | 1.13 to 1.28 | <0.001 | 0.19 | 1.21 | 1.13 to 1.30 | <0.001 |
Q1 (≤1.57) | Ref | Ref | Ref | – | Ref | Ref | Ref | – |
Q2 (1.57–8.38) | 0.97 | 2.66 | 1.01 to 6.97 | 0.04* | 1.03 | 2.80 | 1.02 to 7.67 | 0.04* |
Q3 (8.38–27.33) | 0.93 | 2.52 | 1.03 to 6.16 | 0.04* | 0.99 | 2.71 | 1.06 to 6.89 | 0.03* |
Q4 (>27.33) | 1.54 | 4.67 | 1.78 to 12.15 | 0.002* | 1.52 | 4.55 | 1.70 to 12.19 | 0.003* |
4,4-DDE | 0.64 | 1.91 | 1.48 to 2.45 | <0.001 | 0.64 | 1.89 | 1.42 to 2.52 | <0.001 |
Q1 (≤1.42) | Ref | Ref | Ref | Ref | Ref | Ref | Ref | – |
Q2 (1.42–1.91) | 0.34 | 1.40 | 0.58 to 3.40 | 0.45 | 0.23 | 1.27 | 0.51 to 3.16 | 0.61 |
Q3 (1.91–5.65) | 1.12 | 3.06 | 1.18 to 7.93 | 0.02* | 0.84 | 2.32 | 0.85 to 6.29 | 0.09 |
Q4 (>5.65) | 1.55 | 4.72 | 1.77 to 12.60 | 0.002* | 1.48 | 4.42 | 1.62 to 12.13 | 0.004* |
2,4-DDT | 0.15 | 1.16 | 1.07 to 1.27 | 0.001 | 0.15 | 1.16 | 1.05 to 1.28 | 0.002 |
Q1 (≤1.37) | Ref | Ref | Ref | – | Ref | Ref | Ref | – |
Q2 (1.37–2.30) | −0.05 | 0.95 | 0.36 to 2.51 | 0.91 | −0.21 | 0.81 | 0.29 to 2.23 | 0.68 |
Q3 (2.30–7.21) | 1.07 | 1.03 | 1.02 to 8.41 | 0.04* | 1.19 | 3.29 | 1.10 to 9.85 | 0.03* |
Q4 (>7.21) | 1.23 | 1.46 | 1.46 to 8.05 | 0.005* | 1.22 | 3.41 | 1.37 to 8.47 | 0.008* |
4,4-DDT | 0.21 | 1.24 | 1.11 to 1.38 | <0.001 | 0.20 | 1.22 | 1.09 to 1.38 | 0.001 |
Q1 (≤1.27) | Ref | Ref | Ref | – | Ref | Ref | Ref | – |
Q2 (1.27–1.53) | −0.40 | 0.67 | 0.25 to 1.80 | 0.42 | −0.42 | 0.65 | 0.23 to 1.78 | 0.41 |
Q3 (1.53–4.45) | 0.93 | 2.55 | 0.98 to 6.60 | 0.05 | 0.73 | 2.08 | 0.77 to 5.61 | 0.14 |
Q4 (>4.45) | 1.64 | 5.17 | 1.98 to 13.44 | 0.001* | 1.61 | 5.01 | 1.85 to 13.47 | 0.001* |
Multiple logistic regression. Models were adjusted for total lipid, sex, age, BMI, and disease stage.
*P˂0.05.
alpha-HCH, alpha-hexachlorocyclohexane; beta-HCH, beta-hexachlorocyclohexane; BMI, body mass index; 2,4-DDE, 2,4-dichlorodiphenyldichloroethylene; 4,4-DDE, 4,4-dichlorodiphenyldichloroethylene; 2,4-DDT, 2,4-dichlorodiphenyltrichloroethane; 4,4-DDT, 4,4-dichlorodiphenyltrichloroethane; gamma-HCH, gamma-hexachlorocyclohexane; Ref, reference.